Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1948 2
1949 3
1950 4
1951 4
1952 1
1953 6
1954 6
1955 5
1956 6
1957 4
1958 5
1959 6
1960 4
1961 2
1962 1
1963 5
1964 3
1965 1
1966 2
1967 2
1968 3
1969 5
1970 1
1971 1
1972 8
1973 7
1974 8
1975 4
1976 7
1977 10
1978 1
1979 12
1980 16
1981 15
1982 12
1983 19
1984 19
1985 17
1986 19
1987 21
1988 14
1989 37
1990 28
1991 24
1992 28
1993 36
1994 26
1995 36
1996 36
1997 48
1998 44
1999 52
2000 43
2001 43
2002 49
2003 50
2004 73
2005 74
2006 91
2007 87
2008 112
2009 97
2010 140
2011 139
2012 155
2013 139
2014 154
2015 165
2016 145
2017 160
2018 127
2019 169
2020 225
2021 210
2022 220
2023 178
2024 70

Text availability

Article attribute

Article type

Publication date

Search Results

3,407 results

Results by year

Filters applied: . Clear all
Page 1
Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.
Swain SM, Baselga J, Kim SB, Ro J, Semiglazov V, Campone M, Ciruelos E, Ferrero JM, Schneeweiss A, Heeson S, Clark E, Ross G, Benyunes MC, Cortés J; CLEOPATRA Study Group. Swain SM, et al. N Engl J Med. 2015 Feb 19;372(8):724-34. doi: 10.1056/NEJMoa1413513. N Engl J Med. 2015. PMID: 25693012 Free PMC article. Clinical Trial.
BACKGROUND: In patients with metastatic breast cancer that is positive for human epidermal growth factor receptor 2 (HER2), progression-free survival was significantly improved after first-line therapy with pertuzumab, trastuzumab, and docetaxel, as compared with placebo, …
BACKGROUND: In patients with metastatic breast cancer that is positive for human epidermal growth factor receptor 2 (HER2), progressi …
Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)-related interstitial lung disease/pneumonitis-Focus on proactive monitoring, diagnosis, and management.
Swain SM, Nishino M, Lancaster LH, Li BT, Nicholson AG, Bartholmai BJ, Naidoo J, Schumacher-Wulf E, Shitara K, Tsurutani J, Conte P, Kato T, Andre F, Powell CA. Swain SM, et al. Cancer Treat Rev. 2022 May;106:102378. doi: 10.1016/j.ctrv.2022.102378. Epub 2022 Mar 12. Cancer Treat Rev. 2022. PMID: 35430509 Free article. Review.
Trastuzumab deruxtecan (T-DXd; DS-8201) is an antibody-drug conjugate targeting human epidermal growth factor receptor 2. Interstitial lung disease (ILD)/pneumonitis is an adverse event associated with T-DXd; in most cases, it is low grade (grade 2) and can be treated effe …
Trastuzumab deruxtecan (T-DXd; DS-8201) is an antibody-drug conjugate targeting human epidermal growth factor receptor 2. Interstitia …
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.
Baselga J, Cortés J, Kim SB, Im SA, Hegg R, Im YH, Roman L, Pedrini JL, Pienkowski T, Knott A, Clark E, Benyunes MC, Ross G, Swain SM; CLEOPATRA Study Group. Baselga J, et al. N Engl J Med. 2012 Jan 12;366(2):109-19. doi: 10.1056/NEJMoa1113216. Epub 2011 Dec 7. N Engl J Med. 2012. PMID: 22149875 Free PMC article. Clinical Trial.
BACKGROUND: The anti-human epidermal growth factor receptor 2 (HER2) humanized monoclonal antibody trastuzumab improves the outcome in patients with HER2-positive metastatic breast cancer. ...
BACKGROUND: The anti-human epidermal growth factor receptor 2 (HER2) humanized monoclonal antibody trastuzumab improves the outcome i …
Methods to generate and evaluate zebrafish models of human kidney diseases.
Fatma S, Nayak U, Swain RK. Fatma S, et al. Int J Dev Biol. 2021;65(7-8-9):475-485. doi: 10.1387/ijdb.210041rs. Int J Dev Biol. 2021. PMID: 34549799 Free article. Review.
Hence, identification of the causes of kidney diseases, development of accurate diagnostic methods and novel therapeutics is highly relevant. Model organisms that faithfully recapitulate human diseases play important roles in understanding the disease process and provide v …
Hence, identification of the causes of kidney diseases, development of accurate diagnostic methods and novel therapeutics is highly relevant …
Cumulative human exposure and environmental occurrence of phthalate esters: A global perspective.
Prasad B, Prasad KS, Dave H, Das A, Asodariya G, Talati N, Swain S, Kapse S. Prasad B, et al. Environ Res. 2022 Jul;210:112987. doi: 10.1016/j.envres.2022.112987. Epub 2022 Feb 24. Environ Res. 2022. PMID: 35219627
In the current investigation, the distribution and extent of human exposure of phthalate esters (PAEs) have been reported on global extent based on computed indices. ...More than 90% of total human exposure of PAEs was observed to be from indoor environmental compar …
In the current investigation, the distribution and extent of human exposure of phthalate esters (PAEs) have been reported on global e …
Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study.
Swain SM, Ewer MS, Viale G, Delaloge S, Ferrero JM, Verrill M, Colomer R, Vieira C, Werner TL, Douthwaite H, Bradley D, Waldron-Lynch M, Kiermaier A, Eng-Wong J, Dang C; BERENICE Study Group. Swain SM, et al. Ann Oncol. 2018 Mar 1;29(3):646-653. doi: 10.1093/annonc/mdx773. Ann Oncol. 2018. PMID: 29253081 Free PMC article. Clinical Trial.
3,407 results